| Methods | Double‐blinded randomised trial. |
| Participants | Not known how many women randomised |
| Interventions | Not known dose of oxytocin administered intravenously or 400 mcg of misoprostol administered orally. |
| Outcomes | PPH at 500, PPH at 1000, additional uterotonics, transfusion, change in Hb level, blood loss (mL), fever, shivering. |
| Notes | Method of randomisation not clear and 'Risk of bias' assessment is uncertain. Abstract only. Unable to contact authors. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.